• Volume 20,Issue 6,2021 Table of Contents
    Select All
    Display Type: |
    • >Clinical Research
    • Correlation between social frailty and physical frailty of elderly inpatients

      2021, 20(6):401-405. DOI: 10.11915/j.issn.1671-5403.2021.06.083

      Abstract (810) HTML (0) PDF 383.25 K (1851) Comment (0) Favorites

      Abstract:Objective To analyze the social frailty of inpatients aged 60 years or over with a cross-sectional study, and to explore its relationship with physical function. Methods A total of 258 inpatients aged ≥60 years admitted in our hospital from January to December 2019 were enrolled in this study. Their social frailty was evaluated by Help, Participation, Loneliness, Financial and Talk (HALFT) scale, and those who scored ≥3 were included in the social frailty group, scored 1-2 in the pre-social frailty group, and scored 0 in the non-social frailty group. The prevalence and influencing factors of social frailty were analyzed. SPSS statistics 22.0 was used to perform the statistical analysis. Student′s t test, one-way analysis of variance, Chi-square test, or Fisher exact test was employed in intergroup comparison for different data types. Results There were 31 patients being assigned into the social frailty group, 157 into the pre-social frailty group, and 70 into the non-social frailty group. Compared with the non-social frailty group, the social frailty group were older (P=0.002), more prone to cerebrovascular disease (P=0.016), and had a higher ratio of multiple medications (P=0.029) and a higher incidence of physical frailty (P<0.001). Logistic regression analysis showed that physical frailty was an independent risk factor for social frailty (OR=0.191,95% CI 0.078-0.468, P<0.001). Correlation analysis results indicated that after adjustment for gender and age, the higher HALFT scale score was, the slower walking speed (r=-0.325, P<0.001), the worse handgrip strength (r=-0.151, P=0.018), the lower score of Beijing Longitudinal Study of Aging Physical Activity Questionnaire (BLSA-PAQ, r=-0.322, P=0.001), and the higher score of Fried phenotype frailty scale (r=0.329, P<0.001). Conclusion The prevalence of social frailty is relatively high for the elderly hospitalized patients. Physical frailty is an independent risk factor for social frailty in them, and physical function is associated with social frailty.

    • Risk factors for mortality among elderly patients with severe acute pancreatitis

      2021, 20(6):406-409. DOI: 10.11915/j.issn.1671-5403.2021.06.084

      Abstract (834) HTML (0) PDF 371.25 K (1140) Comment (0) Favorites

      Abstract:Objective To investigate the related factors for in-hospital mortality in elderly patients with severe acute pancreatitis (SAP). Methods Clinical data of 314 SAP patients admitted to the Center for Pancreatitis, Department of Hepatobiliary Surgery in the First Medical Center of Chinese PLA General Hospital from January 2015 to December 2019 were retrospectively collected and analyzed. The patients were divided into aged group (≥60 years) and non-aged group (<60 years). Their conditions and prognosis were compared between 2 age groups. For the aged group, they were further assigned into death subgroup and survival subgroup. The differences were compared and the related factors for mortality were analyzed. R Studio. Inc. Version 1.1.456 was used to make statistical analysis. Wilcoxon test and Chi-square test were adopted for intergroup comparison, and logistic regression analysis was employed to analyze the related factors for death in the elderly SAP patients. Results The aged group had significantly higher mortality rate (34.5% vs 16.9%), longer length of ICU stay[2(0,11) vs 6(1,15)d], higher surgical intervention rate (73.6% vs 58.2%), and fewer undergoing necrosectomies, and larger proportion of respiratory (60.0% vs 32.4%) and circulation supports (58.2% vs 32.4%) when compared with the non-aged group. For the elderly SAP patients, age and requiring renal replacement due to renal failure were independent risk factors for in-hospital mortality. Conclusion The elderly SAP patients have poor prognosis. Special attention should be paid to them for the support of vital organ function.

    • Radial extracorporeal shock wave acupoint therapy for elderly patients with knee osteoarthritis and analysis of its mechanism

      2021, 20(6):410-413. DOI: 10.11915/j.issn.1671-5403.2021.06.085

      Abstract (777) HTML (0) PDF 604.98 K (1253) Comment (0) Favorites

      Abstract:Objective To explore the application value of radial extracorporeal shock wave acupoint therapy in the treatment of the elderly patients with knee osteoarthritis (KOA) and to analyze its mechanism. Methods The study selected 108 elderly KOA patients admitted to Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from January 2018 to June 2019. They were randomized into drug group and shock wave group, with 54 in each group. The former was treated with drug therapy, and the latter with radial extracorporeal shock wave acupoint therapy. The visual analogue scale (VAS), Lysholm score, serum supero-xide dismutase (SOD), tumor necrosis factor-α (TNF-α) and the incidence of related complications were compared between the two groups before and after treatment. SPSS statistics 20.0 was used for data analysis. According to different data type, t test, analysis of variance or χ2 test was used for data comparison between two groups.Results The VAS score of the shock wave group was lower than that of the drug group after treatment, and the Lysholm score was higher than that of the drug group after treatment and 6 months later (P<0.05). After treatment, the SOD of the shock wave group was higher than that of the drug group, and TNF-α was lower than that of the drug group (P<0.05). There was no statistically significant difference in the complication rate between the shock wave group and the drug group (P>0.05). Conclusion Compared with drug therapy, radial extracorporeal shock wave acupoint therapy can promote the recovery of joint function, which may be related to its further reduction of oxidative stress and inflammation.

    • Prognostic factors for fibrosing interstitial lung diseases:a prospective cohort study

      2021, 20(6):414-418. DOI: 10.11915/j.issn.1671-5403.2021.06.086

      Abstract (622) HTML (0) PDF 406.46 K (837) Comment (0) Favorites

      Abstract:Objective To investigate the clinical characteristics of fibrosing interstitial lung diseases, and explore its risk factors of mortality and of developing a progressive phenotype. Methods A total of 58 patients who suffered from fibrosing interstitial lung diseases admitted to the Chinese PLA General Hospital during May and December 2019 were prospectively enrolled in this study. Their clinical data were collected. And chest CT scanning, lung function test and 6-minute walk test(6MWT) were performed. The dyspnea score was assessed with the University of California, San Diego shortness of breath questionnaire (SOBQ). The patients were followed up for 1 year to evaluate the condition. SPSS statistics 19.0 and R 3.6.1 were used to perform the statistical analysis. Student′s t test or Chi-square test was employed for intergroup comparison for different data types. Competing risk model and Fine-Gray competing risk regression model were adopted to extract the risk factors of progressive fibrosis and mortality. Results Of the 58 patients, 35 (60.34%) were diagnosed as idiopathic pulmonary fibrosis (IPF), 14 (24.14%) as interstitial lung disease associated with connective tissue diseases, and 9 (15.52%) as pulmonary fibrosis caused by other causes. Twelve cases (20.69%) developed into progressive fibrotic phenotype, and 8 (13.79%) died, including 6 due to acute exacerbation of fibrosis. Univariate analysis showed that the risk factors for the development of progressive fibrotic phenotype were diagnosis of IPF, high reticular score and honeycombing score in high resolution CT (HRCT) scans, and the risk factors for death were short 6-minute walk distance (the dead had a significantly higher ratio of shorter than 300 m) and higher SOBQ score. Multivariate analysis showed that high HRCT reticular score was the risk factor for progressive fibrotic phenotype (RC=0.687, HR=1.99,95%CI 1.03-3.85,P=0.042), and no risk factors for death were found. Conclusion Patients with IPF, high HRCT reticular and honeycombing scores are at a higher risk of developing progressive fibrotic phenotype. Those with 6-minute walk distance shorter than 300 m and higher SOBQ scores are prone to death.

    • Efficacy of nicorandil in patients with sepsis-induced cardiomyopathy and its effects on prognosis

      2021, 20(6):419-424. DOI: 10.11915/j.issn.1671-5403.2021.06.087

      Abstract (637) HTML (0) PDF 430.64 K (831) Comment (0) Favorites

      Abstract:Objective To explore the efficacy of nicorandil in the patients with sepsis-induced cardiomyopathy (SIC) and its effect on the prognosis. Methods A total of 80 SIC patients admitted to the Intensive Care Unit of the Affiliated Hospital of Xuzhou Medical University from May 2019 to March 2020 were selected and randomly divided into control group and nicorandil group, with 40 in each group. Both groups were given standard anti-septic treatment. Nicoranolil group were given additional nicorandil injection. All patients were treated for consecutive 7 days. Cardiac function and markers of myocardial injury were assessed before and after treatment. Sequential organ failure assessment (SOFA) and changes in acute physiology and chronic health evaluation system Ⅱ (APACHE Ⅱ) were observed before and after treatment. SPSS statistics 22.0 was used for data analysis. Inter-group and intra-group comparison was made using t-test, Mann-Whitney U test and χ2 test. Results After treatment, patients in nicorandil group were found to be better than patients in control group in cardiac function, myocardial injury markers,SOFA and APACHE Ⅱ, with statistically significant difference (all P<0.05). The number of adverse cardiac events during hospitalization and the incidence of severe arrhythmia were significantly decreased in nicorandial group (all P<0.05). Conclusion Compared with standard treatment, nicorandil can reduce myocardial damage in the SIC patients, improve their cardiac function, stabilize the condition, and enhance the prognosis.

    • Status survey and correlation analysis on self-care ability and cognitive function among elderly inpatients in an upper first-class hospital in Haikou City

      2021, 20(6):425-429. DOI: 10.11915/j.issn.1671-5403.2021.06.088

      Abstract (681) HTML (0) PDF 389.31 K (1143) Comment (0) Favorites

      Abstract:Objective To clarify the current situation of self-care ability of daily living and cognitive function in elderly inpatients from an upper first-class hospital in Haikou, Hainan Province, and to analyze the correlation between their self-care ability and cognitive function. Methods The general information questionnaire, Barthel index rating scale, and mini-mental state examination were used to evaluate 219 elderly inpatients from Department of Geriatrics of the hospital from July 2019 to October 2019. SPSS statistics 22.0 was used to perform the statistical analysis. Spearman correlation analysis was employed to analyze the correlation between self-care ability and cognitive function. Results Of 219 elderly patients, 185 (84.5%) showed impaired self-care ability at different severities. Significant difference was seen in the ability among the elderly patients at different ages (H=15.34, P<0.05). There were 125 (57.1%) patients presenting cognitive impairment at different levels. There was a statistical difference in cognitive function among those with different education levels (H=9.57, P<0.05). Self-care ability of daily living was positively correlated with overall cognitive function in elderly inpatients (r=0.26, P<0.01). Conclusion Elderly inpatients have higher prevalence of impaired self-care ability of daily living and cognitive impairment, and the two abilities are positively correlated.

    • Application of transcatheter aortic valve replacement in very old patients with aortic stenosis

      2021, 20(6):430-433. DOI: 10.11915/j.issn.1671-5403.2021.06.089

      Abstract (564) HTML (0) PDF 352.63 K (751) Comment (0) Favorites

      Abstract:Objective To investigate the efficacy and safety of transcatheter aortic valve replacement (TAVR) in the treatment of very old patients with aortic stenosis. Methods Clinical data of 142 aged patients with aortic stenosis undergoing TAVR in our hospital from January 2019 to December 2020 were collected and retrospectively analyzed. Among them, 22 patients (≥80 years old) were assigned into the very old group, and the other 120 ones (65-80 years old) into the elderly group. The perioperative outcomes were compared between the 2 groups. SPSS statistics 20.0 was used for statistical analysis. Inter-group comparison was performed using Chi-square test, student′s t test or Fisher exact test depending on different date types. Results During the perioperative period, there were no statistical differences in the ratios of being converted to surgery (0.0% vs 1.7%), intraoperative extracorporeal circulation (0.0% vs 0.8%), intraoperative left ventricular rupture (0.0% vs 0.8%), post-operative ECMO assisted circulation (0.0% vs 1.7%), incidence rate of postoperative peripheral vascular complications (0.0% vs 3.3%), postoperative pacemaker implantation (4.5% vs 8.3%), postoperative disabled stroke (0.0% vs 0.8%), and perioperative mortality rate (0.0% vs 0.8%) between the very old group and the elderly group (P>0.05). There were 6 patients (4.2%) undergoing TAVR with non-femoral artery approach, including 1 patient (0.7%) with left subclavian artery approach, 1 patient (0.7%) with ascending aorta approach, and 3 patients (2.5%) with transcarotid approach in the elderly group; and 1 case (4.5%) in the very old group via carotid artery approach, and no statistical difference was seen between the 2 groups (P>0.05). Conclusion TAVR is an effective and safe treatment for elderly patients with aortic stenosis.

    • Survey on potentially inappropriate medications in very old hospitalized patients and analysis of influencing factors

      2021, 20(6):434-438. DOI: 10.11915/j.issn.1671-5403.2021.06.090

      Abstract (2351) HTML (0) PDF 424.98 K (1103) Comment (0) Favorites

      Abstract:Objective To survey the prevalence of potentially inappropriate medication (PIM) in very old hospitalized patients by combining the 2019 American Geriatrics Society (AGS) Beers Criteria and 2014 Screening Tool of Older Persons′ Prescriptions (STOPP) Criteria, and investigate the influencing factors. Methods A retrospective analysis was carried out on the 1023 inpatients aged ≥ 80 years in the Second Medical Center of Chinese PLA General Hospital from January 2015 to December 2020. PIM prevalence was assessed based on the 2019 AGS Beers Criteria and 2014 STOPP Criteria. SPSS statistics 22.0 was used to perform the statistical analysis. Logistic regression analysis was employed to analyze the influencing factors for PIM. Results According to the 2019 AGS Beers Criteria and 2014 STOPP Criteria, the prevalence of PIM was 79.3% (811 cases) and 59.1% (605 cases), respectively. And the consistency of the 2 screening criteria was quite low (Kappa=0.238, P<0.001). The most frequently prescribed PIM was Benzodiazepines according to the both criteria. Screening Tool to Alert to Right Treatment (START) Criteria found that the potential prescribing omission (PPO) incidence was 52.9% (541 cases). Logistic regression analysis indicated that age, Charlson comorbidity index and number of concomitant medications were risk factors for PIM. Conclusion The prevalence of PIM is quite high in the very old hospitalized patients. Combining Beers and STOPP criteria are effective to enhance the detection of PIM.

    • Clinical efficacy and safety of cisplatin combined with paclitaxel or 5-fluorouracil and concurrent radiotherapy for elderly patients with advanced esophageal cancer

      2021, 20(6):439-443. DOI: 10.11915/j.issn.1671-5403.2021.06.091

      Abstract (562) HTML (0) PDF 446.18 K (1927) Comment (0) Favorites

      Abstract:Objective To compare the efficacy and safety of cisplatin combined with paclitaxel or 5-fluorouracil and concurrent radiotherapy for elderly patients with advanced esophageal cancer. Methods A total of 102 elderly patients with advanced esophageal cancer who were treated in our hospital from May 2016 to June 2018 were recruited as the research objects, and then randomly divided into paclitaxel group (n=52) and 5-fluorouracil group (n=50). The therapeutic efficiency, 2-year survival rate, gastrointestinal side effects, kidney and hepatic impairment and bone marrow suppression were compared and analyzed between the two groups. SPSS statistics 25.0 was used to perform the statistical analysis. Chi-square test and Fisher exact test were employed for data analyses, and Kaplan-Meier analysis and Log-rank test were adopted to evaluate clinical efficacy and safety of the regimens. Results The efficiency rate was 65.38% (34/52) and 62.00% (31/50) respectively in the paclitaxel group and 5-fluorouracil group (P>0.05). But the control rate was 94.23% (49/52) and 70.00% (35/50) respectively, with statistically difference between the two groups (P=0.032). There was no significant difference in 2-year survival rate (P>0.05). The incidences of nausea and vomiting, and bone marrow suppression were 40.38% (21/52) and 67.31% (35/52) respectively in the paclitaxel group, and 74.00% (37/50) and 28.00% (14/50) in the 5-fluorouracil group (P<0.05). The incidences of kidney and hepatic impairment did not differ between two groups. Conclusion The regimen of paclitaxel combined with cisplatin and concurrent radiotherapy shows a similar therapeutic efficacy as the regimen with 5-fluorouracil+cisplatin+concurrent radiotherapy for the elderly patients with advanced esophageal cancer, and causes less adverse reactions in gastrointestinal tract and less bone marrow suppression in the patients.

    • Anticoagulant effect of bivalirudin in patients with coronary heart disease and end-stage renal disease during percutaneous coronary intervention

      2021, 20(6):444-448. DOI: 10.11915/j.issn.1671-5403.2021.06.092

      Abstract (600) HTML (0) PDF 421.60 K (1129) Comment (0) Favorites

      Abstract:Objective To retrospectively analyze anticoagulant effect of bivalirudin and heparin in the patients with coronary heart disease(CHD) and end-stage renal disease(ESRD)during percutaneous coronary intervention(PCI). Methods A total of 62 patients with CHD complicated with ESRD were selected for the study, who received PCI treatment in Wuhan Puren Hospital from October 2015 to December 2018. According to the different anticoagulants administered during operation, they were divided into control group (heparin, n=29) and observation group (bivalirudin, n=33). The two groups were compared in contrast-induced nephropathy (CIN) during hospitalization, net adverse clinical events (NACE) and major adverse cardiac and cerebrovascular events (MACCE) in 30 days and 1 year after operation. The difference of MACCE sub-indexes between the two groups was observed. SPSS statistics 25.0 was used for data analysis, and t-test or Chi-square test was used for comparison between groups. Results During hospitalization, 3 patients developed CIN in both groups without significant difference (P>0.05). At 30 days after the operation, NACE and all bleeding events in the observation group were lower than those in the control group, and the differences were significant (P<0.05). There was no significant difference in MACCE between the two groups (P>0.05). At postoperative 1 year, NACE was significantly lower in the observation group than the control group (P<0.05), and there was no significant difference in MACCE and all bleeding events between the two groups (P>0.05). Conclusion Bivalirudin reduces the NACE and all bleeding events more significantly than heparin within 30 days after PCI in CHD patients with ESRD, showing better anticoagulant effect. The advantage of risk reduction of NACE may last till 1 year after PCI. Bivalirudin is more suitable for anticoagulation in patients with CHD and ESRD during PCI.

    • Etiology and clinical characteristics of spontaneous convex subarachnoid hemorrhage complicated with acute cerebral infarction

      2021, 20(6):449-452. DOI: 10.11915/j.issn.1671-5403.2021.06.093

      Abstract (582) HTML (0) PDF 328.32 K (946) Comment (0) Favorites

      Abstract:Objective To investigate the causes and clinical characteristics of spontaneous convexal subarachnoid hemorrhage (cSAH) complicated with acute ischemic stroke (AIS). Methods Clinical data of 160 cases of cSAH patients hospitalized in our department from January 2012 to January 2020 were collected and retrospectively analyzed. Patients were divided into cSAH group and cSAH combined with AIS group according to whether patients were complicated with AIS. SPSS statistics 19.0 was used to perform the statistical analysis. Student′s t test or Chi-square test was employed for intergroup comparison according to different data types. Results Among the 160 cSAH patients, 23 cases were combined with AIS. Comparison of clinical data between the 2 groups showed that the patients combined with AIS had significantly higher male ratio, older age, and greater ratios of hypertension, diabetes, hyperlipidemia, chronic cerebral infarction and smoking than the cSAH patients (P<0.05). What′s more, limb weakness and numbness and middle cerebral artery stenosis were more common in the cSAH combined with AIS group than the cSAH group (P<0.05). Conclusion For the elderly cSAH patients with cerebrovascular disease risk factors, especially those with intracranial large vessel stenosis, great attention should be paid to the symptoms and signs of focal nervous system involvement, and the focus should be on improving the head MRI and cerebrovascular examination to determine whether AIS is complicated, so as to avoid missed diagnosis and misdiagnosis.

    • >Basic Research
    • Expression of hypoxia-inducible lipid droplet-associated protein in diabetic patients combined with abdominal aortic aneurysm

      2021, 20(6):453-458. DOI: 10.11915/j.issn.1671-5403.2021.06.094

      Abstract (677) HTML (0) PDF 899.90 K (818) Comment (0) Favorites

      Abstract:Objective To find the differentially expressed genes (DEGs) in diabetic patients combined with abdominal aortic aneurysms (AAA) through bioinformatics analysis, then clarify their functions, and explore the roles in the pathogenesis. Methods The expression profiles of GSE21321 (diabetes mellitus) and GSE7084 (AAA) were downloaded from the Gene Expression Omnibus (GEO) database. The 2 microarray datasets were integrated to obtain DEGs by screening at P<0.05 and expression changes greater than 2 times. The subcellular localization of obtained proteins was analyzed by using Genscript database and Predictprotein platform, which were further verified with fluorescence co-localization analysis. The protein interactions of hypoxia-inducible lipid droplet-associated (HILPDA)were analyzed by the search tool for the retrival of interacting genes (STRING) database. SPSS statistics 13.0 was used for data analysis. Difference of measurement data was compared with analysis of variance. Results HILPDA was screen out, with up-regulation by 11.35 times in type 2 diabetes mellitus and by 6.4 times in AAA. The results of subcellular localization predicted that HILPDA is mostly distributed in the nucleus and mitochondria. Immunofluorescence co-localization analysis confirmed that HILPDA had a higher expression in the nucleus and the mitochondria of vascular smooth muscle cells; protein-protein interaction (PPI) network analysis confirmed that HILPDA-related proteins are related to cellular response to hypoxia and lipid droplet. HILPDA protein expression was significantly higher in the AAA tissues than the peritumor arterial tissues (control group) [(47.2±5.6)% vs (71.5±4.7)%, P<0.01].Conclusion HILPDA gene might have potential guiding value in the clinical studies concerning the diagnosis and treatment of diabetes accompanied with AAA.

    • >Review
    • Role of autophagy in metabolic syndrome-related cardiovascular aging

      2021, 20(6):464-468. DOI: 10.11915/j.issn.1671-5403.2021.06.097

      Abstract (737) HTML (0) PDF 419.37 K (928) Comment (0) Favorites

      Abstract:Metabolic syndrome is a complexity of metabolic derangement with quite high and ever-rising prevalence. Its related diseases, such as obesity, insulin resistance, diabetes, hypertension, and dyslipidemia, all contribute to premature cardiovascular aging. Autophagy-lysosomal pathways represent the major cellular machineries for degradation and removal of damaged or long-lived proteins and organelles produced during the process of cardiovascular aging, and take part in the occurrence and development of premature cardiovascular aging which is associated with metabolic syndrome. To investigate new therapeutic avenue for premature cardiovascular aging under diversified metabolic abnormalities, it is of great importance to grasp the accurate role of autophagy in regulation of the process. In the article, we briefly review the integral role of autophagy in premature cardiovascular aging based on the present domestic and abroad researches at home and abroad in order to provide a new theoretical basis for delaying premature cardiovascular aging and improving the dysfunction of cardiovascular system.

    • Clinical application of bedside ultrasound in critically illed elderly patients

      2021, 20(6):469-472. DOI: 10.11915/j.issn.1671-5403.2021.06.098

      Abstract (563) HTML (0) PDF 396.43 K (974) Comment (0) Favorites

      Abstract:The critical elderly patients are usually frail with multiple degenerated organs and comorbidity of chronic diseases, characterized by different clinical manifestations, severe conditions, rapid progression, and high mortality. In recent years, bedside ultrasound has become an important visualized examination method for its advantages of non-invasiveness, convenience, speed, non-radioactivity and real-time dynamic checks, repeatability, and integrative examination of multiple spots. This paper reviews the application of bedside ultrasound in elderly patients with critical illnesses in cardiovascular, respiratory, urinary, and digestive systems.

    • Research progress in effects of gender and body mass index on patients with obstructive sleep apnea-hypopnea syndrome

      2021, 20(6):473-476. DOI: 10.11915/j.issn.1671-5403.2021.06.099

      Abstract (555) HTML (0) PDF 376.65 K (1184) Comment (0) Favorites

      Abstract:Obstructive sleep apnea-hypopnea syndrome (OSAHS), the most common sleep disorder, negatively impacts different body system, cardiovascular system in particular. Continuous positive airway pressure is its most widely used and effective treatment, significantly improving night hypoxia and sleep fragments in OSAHS patients. The incidence, severity and prognosis of OSAHS are affected by such factors as age, gender and body mass index (BMI). OSAHS has historically been considered a male disease. However, recent studies have found that the clinical manifestations, prognosis and treatment options in women are different from men. Moreover, increased BMI will lead to different outcomes due to the gender differences. This paper reviews the effects of BMI and gender on OSAHS patients.

    • Skeletal muscle mitochondrial dysfunction and sarcopenia

      2021, 20(6):477-480. DOI: 10.11915/j.issn.1671-5403.2021.100.

      Abstract (647) HTML (0) PDF 383.09 K (2632) Comment (0) Favorites

      Abstract:Mitochondrial dysfunction caused by mitochondrial deoxyribonucleic acid mutation, excess reactive oxygen species (ROS) production, decreased biogenesis, dynamics dysregulation, and mitophagy disorder might be the main factor leading to the occurrence and development of sarcopenia. Nowadays, physical exercise, because of its enhancing or restoring mitochondrial function, has been well accepted as an essential regime in the prevention and treatment of the disease. ROS-targeted therapies, including vitamin E/C, resveratrol, and targeted antioxidants, can regulate mitochondria to improve muscle quantity and function. Improving mitochondrial function can be a target for sarcopenia treatment.

Superintendor:Chinese PLA General Hospital

Sponsor:Medical Innovation Research Division, Chinese PLA General Hospital/ National Clinical Research Center for Geriatric Diseases (Chinese PLA General Hospital)/Department of Cardiology, Sixth Medical Center, Chinese PLA General Hospital

Editor-in-Chief:Fan Li

Executive Editor:Chen Yundai

Tel:010-66936756

E-mail: zhlndqg@mode301.cn

ISSN:1671-5403

CN:11-4786/R

Founding Date:2002

Publishing Cycle:Monthly

Postal Code:82-408

  • Most Read
  • Most Cited
  • Most Downloaded
Press search
Search term
From To